Research reports published in the Journal of Cancer Epidemiology, Biomarkers, and Prevention show that there is a negative correlation between circulating 25-hydroxyvitamin D [25 (OH) D] levels and liver cancer risk and chronic liver disease mortality To associate. Gabriel Y. Lai, author of the Department of Cancer Control and Population Science at the National Cancer Institute, and colleagues say that there has been a link between reduced vitamin D levels and chronic liver disease and ailse ae observed in laboratory studies, but there has been little epidemiology Research assesses these associations.
Áiríodh sa staidéar 854 fear a chaitheann tobac ón bhFionlainn a ghlac páirt i staidéir ar chosc ailse alfa-tócaifearóil, béite-carotéin agus a thomhais leibhéil vitimín D óna samplaí serum. Le linn beagnach 25 bliain d'obair leantach, diagnóisíodh 202 othar le hailse ae agus fuair 225 othar bás le galar ae. D'fheidhmigh 427 ábhar gan galar ae nó ailse ae mar rialuithe. I measc na n-ábhar le tiúchan serum 25 (OH) D níos lú ná 10 ng / mL (ng / mL), tháinig méadú 91% ar an mbaol ailse ae i gcomparáid leo siúd a bhfuil leibhéal tiúchana níos mó ná 20 ng / mL acu, ainsealach An riosca. de bhás galar ae méadú 67%.
"Tugann ár dtorthaí le fios go bhféadfadh éifeacht choisctheach a bheith ag vitimín D ar ailse ae agus galar ae ainsealach," a dúirt an Dr Lai agus a chomhghleacaithe. “Ní mór do staidéir amach anseo measúnú a dhéanamh ar an ngaol idir vitimín D agus ailse ae agus galar ae i ndaonraí eile, go háirithe iad siúd a bhfuil fachtóirí riosca éagsúla acu.”
